Ghent University Academic Bibliography

Your filters: cql: keyword exact "INTERLEUKIN-1"

Add to list
- Journal Article
- A1
- open access
Rethinking IL-1 antagonism in respiratory viral infections : a role for IL-1 signaling in the development of antiviral T cell immunity

Bram Van Den Eeckhout (UGent) , Marlies Ballegeer (UGent) , Jozefien De Clercq (UGent) , Elianne Burg (UGent) , Xavier Saelens (UGent) , Linos Vandekerckhove (UGent) and Sarah Gerlo (UGent)

(2023) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24(21).
Add to list
- Journal Article
- A1
- open access
Nonredundancy of IL-1 alpha and IL-1 beta is defined by distinct regulation of tissues orchestrating resistance versus tolerance to infection

Kevin Eislmayr, Annika Bestehorn, Luisa Morelli, Martina Borroni, Lieselotte Vande Walle (UGent) , Mohamed Lamkanfi (UGent) and Pavel Kovarik

(2022) SCIENCE ADVANCES. 8(9).
Add to list
- Journal Article
- A1
- open access
Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection : from prognostic marker to therapeutic agent

Jozefien Declercq (UGent) , Elisabeth De Leeuw (UGent) and Bart Lambrecht (UGent)

(2022) CYTOKINE. 157.
Add to list
- Journal Article
- A1
- open access
Interleukin-1 as innate mediator of T cell immunity

Bram Van Den Eeckhout (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2021) FRONTIERS IN IMMUNOLOGY. 11.
Add to list
IL1 beta promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D

Mate Kiss, Lieselotte Vande Walle (UGent) , Pedro Henrique Viana Saavedra (UGent) , Els Lebegge, Helena Van Damme, Aleksandar Murgaski, Junbin Qian, Manuel Ehling, Samantha Pretto, Evangelia Bolli, et al.

(2021) CANCER IMMUNOLOGY RESEARCH. 9(3). p.309-323
Add to list
- Journal Article
- A1
- open access
Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant

Bram Van Den Eeckhout (UGent) , Lien Van Hoecke (UGent) , Elianne Burg (UGent) , Sandra Van Lint (UGent) , Frank Peelman (UGent) , Niko Kley, Gilles Uzé, Xavier Saelens (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2020) NPJ VACCINES. 5(1).
Add to list
- Journal Article
- A1
- open access
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis

Margreet Kloppenburg, Charles Peterfy, Ida K Haugen, Féline Kroon, Su Chen, Li Wang, Wei Liu, Gwen Levy, Roy M Fleischmann, Francis Berenbaum, et al.

(2019) ANNALS OF THE RHEUMATIC DISEASES. 78(3). p.413-420
Add to list
- Journal Article
- A1
- open access
The preventive effects of two nutraceuticals on experimentally induced acute synovitis

Eline Van de Water, Maarten Oosterlinck (UGent) , Michèle Dumoulin (UGent) , NM Korthagen, PR van Weeren, J van den Broek, H Everts, Frederik Pille (UGent) and DA van Doorn

(2017) EQUINE VETERINARY JOURNAL. 49(4). p.532-538
Add to list
- Journal Article
- A1
- open access
Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains

Annelies Michiels, Ioannis Arsenakis, Filip Boyen (UGent) , Roman Krejci, Freddy Haesebrouck (UGent) and Dominiek Maes (UGent)

(2017) BMC VETERINARY RESEARCH. 13.
Add to list
- Journal Article
- A1
PID in disguise : molecular diagnosis of IRAK-4 deficiency in an adult previously misdiagnosed with autosomal dominant hyper IgE syndrome

Glynis Frans, Leen Moens, Rik Schrijvers, Greet Wuyts, Bernard Bouckaert, Heidi Schaballie (UGent) , Lieven Dupont, Xavier Bossuyt, Anniek Corveleyn and Isabelle Meyts

(2015) JOURNAL OF CLINICAL IMMUNOLOGY. 35(8). p.739-744

Academic Bibliography

Rethinking IL-1 antagonism in respiratory viral infections : a role for IL-1 signaling in the development of antiviral T cell immunity

Nonredundancy of IL-1 alpha and IL-1 beta is defined by distinct regulation of tissues orchestrating resistance versus tolerance to infection

Inflammasomes and IL-1 family cytokines in SARS-CoV-2 infection : from prognostic marker to therapeutic agent

Interleukin-1 as innate mediator of T cell immunity

IL1 beta promotes immune suppression in the tumor microenvironment independent of the inflammasome and gasdermin D

Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant

Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis

The preventive effects of two nutraceuticals on experimentally induced acute synovitis

Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains

PID in disguise : molecular diagnosis of IRAK-4 deficiency in an adult previously misdiagnosed with autosomal dominant hyper IgE syndrome

Contents

Support

Contact